Effectiveness of Inhaled Corticosteroids in Preschool Children With Acute Dyspnea and Wheeze

NCT00962299 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2018-01-04

No results posted yet for this study

Summary

The aim of the study is to investigate whether inhaled corticosteroids after a first hospital admission for acute dyspnea and wheeze is effective in reducing subsequent episodes of these complaints in children aged 1 to 4 years.

Conditions

Interventions

DRUG

Beclomethasone

Beclometasone 100 ug b.i.d. by metered dose inhaler with spacer for 6 months

DRUG

Placebo

Placebo once a day by metered dose inhaler with spacer for 6 months

Sponsors & Collaborators

  • Princess Amalia Children's Clinic

    lead OTHER

Principal Investigators

  • N Doornebal, MD · Princess Amalia Children's Clinic

  • J Bekhof, MD · Princess Amalia Children's Clinic

  • P LP Brand, MDPhD · Princess Amalia Children's Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00962299 on ClinicalTrials.gov